Stop Believing These 3 Common Myths About Prostate Cancer

PSA tests, prostate surgery often misunderstood

Stop Believing These 3 Common Myths About Prostate Cancer

When it comes to prostate cancer screening and treatment, misconceptions persist.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

It’s important to separate myths from facts:

Myth 1: PSA (or prostate-specific-antigen) testing mostly benefits men over 65

Although PSA screening is mostly performed in men over 65, the men who really benefit from the test are young and have a PSA pattern that highly suggests cancer. If these young men take their test results seriously, they are biopsied for high-grade cancer and then treated and cured of their cancer.

RELATED: Medicare Considers Coverage of Genetic Prostate Cancer Test

Advertising Policy

Myth 2: A high PSA score always means prostate cancer

Other conditions, including non-cancerous prostate enlargement, can cause higher PSA, so a biopsy is the only way to know for sure.

Myth 3: Prostate surgery ruins your urinary control and your sex life

In experienced hands and the early stages of prostate cancer, long-term issues with urinary leakage are minimal. In the majority of men with early stage prostate cancer, it’s possible to do nerve-sparing surgery and have normal erections.

Remember that prostate cancer can often be detected early through screening. A digital rectal exam is one screening method, and a PSA is another.

Advertising Policy

According to the American Cancer Society, other than skin cancer, prostate cancer is the most common cancer in American men.


Eric A. Klein, MD

Eric A. Klein, MD, is an international leader in the biology and management of prostate cancer. Dr. Klein serves as Chairman of the Glickman Urological & Kidney Institute.
Advertising Policy